| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| IRMDIRadimed Corporation | 1.3B | 102.57 | 68.38 | 11.71% | 26.31% | 21.54% | 1.35% | 0.00 |
| BRKRBruker Corporation | 7.52B | 49.46 | 65.08 | 13.56% | -0.61% | -0.84% | 1.81% | 1.24 |
| STESTERIS plc | 26.33B | 268.26 | 43.27 | 6.24% | 12.07% | 9.8% | 2.95% | 0.33 |
| FONRFONAR Corporation | 114.98M | 18.64 | 15.15 | 1.43% | 7.08% | 4.62% | 6.48% | 0.24 |
| HYPRHyperfine, Inc. | 100.18M | 1.22 | -2.18 | 16.84% | -378.17% | -149.05% | 0.01 | |
| PACBPacific Biosciences of California, Inc. | 709.48M | 2.35 | -2.20 | -23.19% | -325.8% | -13.95% | 1.33 | |
| IRIXIRIDEX Corporation | 23.21M | 1.35 | -2.50 | -6.17% | -10.04% | -108.67% | 2.21 | |
| MASS908 Devices Inc. | 199.79M | 5.52 | -2.60 | 18.72% | -7.17% | -3.03% | 0.06 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 1.3M | 8.58M | 9.9M | 11.28M |
| Revenue Growth % | - | - | - | - | 5.58% | 0.15% | 0.14% |
| Cost of Goods Sold | 35K | 53K | 208K | 2.82M | 15.46M | 16.5M | 21.89M |
| COGS % of Revenue | - | - | - | 2.16% | 1.8% | 1.67% | 1.94% |
| Gross Profit | -35K | -53K | -208K | -1.51M | -6.88M | -6.59M | -10.61M |
| Gross Margin % | - | - | - | -1.16% | -0.8% | -0.67% | -0.94% |
| Gross Profit Growth % | - | -0.51% | -2.92% | -6.27% | -3.55% | 0.04% | -0.61% |
| Operating Expenses | 1.9M | 22.57M | 43.92M | 60.05M | 72.33M | 56M | 46.14M |
| OpEx % of Revenue | - | - | - | 46.05% | 8.43% | 5.65% | 4.09% |
| Selling, General & Admin | 1.23M | 19.85M | 34.71M | 41.74M | 45.63M | 28.39M | 25.75M |
| SG&A % of Revenue | - | - | - | 32.01% | 5.32% | 2.87% | 2.28% |
| Research & Development | 672K | 2.72M | 9.21M | 17.12M | 26.51M | 26.05M | 20.18M |
| R&D % of Revenue | - | - | - | 13.13% | 3.09% | 2.63% | 1.79% |
| Other Operating Expenses | 0 | 0 | 0 | 1.18M | 191K | 1.55M | 206K |
| Operating Income | -1.9M | -22.57M | -43.92M | -61.56M | -109.71M | -62.59M | -56.75M |
| Operating Margin % | - | - | - | -47.21% | -12.79% | -6.32% | -5.03% |
| Operating Income Growth % | - | -10.85% | -0.95% | -0.4% | -0.78% | 0.43% | 0.09% |
| EBITDA | -1.87M | -22.52M | -43.72M | -59.27M | -98.2M | -50.78M | -45.01M |
| EBITDA Margin % | - | - | - | -45.45% | -11.45% | -5.13% | -3.99% |
| EBITDA Growth % | - | -11.05% | -0.94% | -0.36% | -0.66% | 0.48% | 0.11% |
| D&A (Non-Cash Add-back) | 35K | 53K | 208K | 2.29M | 11.51M | 11.81M | 11.73M |
| EBIT | -1.9M | -22.57M | -43.81M | -61.56M | -87.21M | -59.66M | -56.75M |
| Net Interest Income | 0 | 8K | 108K | -288K | 789K | 1.65M | 2.87M |
| Interest Income | 0 | 8K | 108K | 0 | 789K | 1.65M | 2.87M |
| Interest Expense | 5K | 0 | 0 | 288K | 0 | 0 | 0 |
| Other Income/Expense | -5K | 8K | 108K | -288K | -14.67M | 1.47M | 2.87M |
| Pretax Income | -1.91M | -22.56M | -43.81M | -61.85M | -108.92M | -61.12M | -53.87M |
| Pretax Margin % | - | - | - | -47.43% | -12.7% | -6.17% | -4.77% |
| Income Tax | 5K | 0 | 0 | -48K | -3.68M | -339K | -358K |
| Effective Tax Rate % | 1% | 1% | 0.99% | 1% | 0.97% | 0.99% | 0.99% |
| Net Income | -1.91M | -22.55M | -43.5M | -61.8M | -105.24M | -60.78M | -53.52M |
| Net Margin % | - | - | - | -47.39% | -12.27% | -6.14% | -4.74% |
| Net Income Growth % | - | -10.82% | -0.93% | -0.42% | -0.7% | 0.42% | 0.12% |
| Net Income (Continuing) | -1.91M | -22.56M | -43.81M | -61.8M | -113.24M | -60.78M | -53.52M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.06 | -0.49 | -1.22 | -1.28 | -2.01 | -1.08 | -0.91 |
| EPS Growth % | - | -7.77% | -1.49% | -0.05% | -0.57% | 0.46% | 0.16% |
| EPS (Basic) | -0.06 | -0.49 | -1.22 | -1.28 | -2.01 | -1.08 | -0.91 |
| Diluted Shares Outstanding | 34.17M | 45.72M | 35.65M | 48.22M | 52.23M | 56.37M | 58.62M |
| Basic Shares Outstanding | 34.17M | 45.72M | 35.65M | 48.22M | 52.23M | 56.37M | 58.62M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 1.7M | 9.64M | 219.79M | 94.86M | 82.46M | 88.64M | 78.68M |
| Cash & Short-Term Investments | 5K | 8.07M | 213.47M | 88.71M | 77.62M | 82.38M | 73.21M |
| Cash Only | 5K | 8.07M | 213.47M | 66.64M | 38.46M | 56.38M | 39.3M |
| Short-Term Investments | 0 | 0 | 0 | 22.07M | 39.16M | 26.01M | 33.9M |
| Accounts Receivable | 0 | 0 | 0 | 1.05M | 977K | 1.48M | 1.8M |
| Days Sales Outstanding | - | - | - | 294.18 | 41.57 | 54.69 | 58.39 |
| Inventory | 0 | 0 | 0 | 3.13M | 2.41M | 2.36M | 1.49M |
| Days Inventory Outstanding | - | - | - | 405.57 | 57 | 52.13 | 24.89 |
| Other Current Assets | 0 | 0 | 6.33M | 1.97M | 1.45M | 1.14M | 1.35M |
| Total Non-Current Assets | 156K | 2.23M | 16.36M | 268.31M | 171.47M | 130.01M | 131.32M |
| Property, Plant & Equipment | 156K | 754K | 15.38M | 39.16M | 44.7M | 46.92M | 49.2M |
| Fixed Asset Turnover | - | - | - | 0.03x | 0.19x | 0.21x | 0.23x |
| Goodwill | 0 | 0 | 0 | 58.3M | 7.42M | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 101.83M | 91.22M | 80.61M | 70M |
| Long-Term Investments | 0 | 145K | 316K | 67.84M | 25.2M | 327K | 337K |
| Other Non-Current Assets | 0 | 1.34M | 661K | 1.18M | 2.93M | 2.16M | 11.79M |
| Total Assets | 1.85M | 11.87M | 236.15M | 363.17M | 253.93M | 218.65M | 210M |
| Asset Turnover | - | - | - | 0.00x | 0.03x | 0.05x | 0.05x |
| Asset Growth % | - | 5.4% | 18.89% | 0.54% | -0.3% | -0.14% | -0.04% |
| Total Current Liabilities | 8.24M | 20.26M | 4.48M | 52.75M | 17.07M | 15.52M | 13.97M |
| Accounts Payable | 82K | 475K | 435K | 3.13M | 3.62M | 3.3M | 2.21M |
| Days Payables Outstanding | 855.14 | 3.27K | 763.34 | 406.22 | 85.45 | 73.08 | 36.83 |
| Short-Term Debt | 0 | 0 | 519K | 145K | 740K | 3.49M | 3.06M |
| Deferred Revenue (Current) | 0 | 1000K | 0 | 247K | 182K | 543K | 140K |
| Other Current Liabilities | 0 | 0 | 1.08M | 44.73M | 7.55M | 3.41M | 3.85M |
| Current Ratio | 0.21x | 0.48x | 49.06x | 1.80x | 4.83x | 5.71x | 5.63x |
| Quick Ratio | 0.21x | 0.48x | 49.06x | 1.74x | 4.69x | 5.56x | 5.52x |
| Cash Conversion Cycle | - | - | - | 293.54 | 13.12 | 33.73 | 46.45 |
| Total Non-Current Liabilities | 82K | 386K | 923K | 18.27M | 12.18M | 7.61M | 6.91M |
| Long-Term Debt | 0 | 0 | 0 | 3.8M | 3.48M | 0 | 0 |
| Capital Lease Obligations | 0 | 386K | 923K | 950K | 398K | 4.04M | 3.64M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 7.06M | 3.33M | 2.95M | 2.58M |
| Other Non-Current Liabilities | 0 | 0 | 0 | 6.05M | 4.57M | 612K | 695K |
| Total Liabilities | 8.24M | 20.65M | 5.4M | 71.02M | 29.25M | 23.13M | 20.88M |
| Total Debt | 0 | 526K | 1.44M | 5.77M | 4.62M | 8.4M | 7.45M |
| Net Debt | -5K | -7.55M | -212.03M | -60.87M | -33.84M | -47.98M | -31.86M |
| Debt / Equity | - | - | 0.01x | 0.02x | 0.02x | 0.04x | 0.04x |
| Debt / EBITDA | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - |
| Interest Coverage | -380.80x | - | - | -213.74x | - | - | - |
| Total Equity | -6.38M | -8.78M | 230.75M | 292.15M | 224.68M | 195.51M | 189.12M |
| Equity Growth % | - | -0.38% | 27.29% | 0.27% | -0.23% | -0.13% | -0.03% |
| Book Value per Share | -0.19 | -0.19 | 6.47 | 6.06 | 4.30 | 3.47 | 3.23 |
| Total Shareholders' Equity | -6.38M | -8.78M | 230.75M | 292.15M | 224.68M | 195.51M | 189.12M |
| Common Stock | 58K | 75K | 131K | 149K | 158K | 165K | 181K |
| Retained Earnings | -18.04M | -40.6M | -84.42M | -146.21M | -251.46M | -320.23M | -373.75M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -83K | 0 | 0 | -607K | -1.97M | -305K | -1K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Cash from Operations | -3.67M | -5.52M | -21.49M | -38.07M | -43.38M | -44.78M | -36.6M |
| Operating CF Margin % | - | - | - | -29.2% | -5.06% | -4.52% | -3.24% |
| Operating CF Growth % | - | -0.5% | -2.89% | -0.77% | -0.14% | -0.03% | 0.18% |
| Net Income | -1.91M | -22.56M | -43.81M | -61.8M | -105.24M | -60.78M | -53.52M |
| Depreciation & Amortization | 35K | 53K | 208K | 2.29M | 11.51M | 11.81M | 11.73M |
| Stock-Based Compensation | 115K | 16.25M | 24.78M | 18.81M | 18.62M | 6.84M | 7.26M |
| Deferred Taxes | 0 | -16.35M | -25.3M | -116K | -3.73M | -377K | -377K |
| Other Non-Cash Items | 185K | 16.35M | 25.3M | -2K | 52.4M | 5.21M | -572K |
| Working Capital Changes | -1.91M | 741K | -2.66M | 2.75M | -16.95M | -7.48M | -1.13M |
| Change in Receivables | 0 | 0 | 0 | -40K | 74K | -507K | -321K |
| Change in Inventory | 0 | 0 | 0 | 864K | 0 | 0 | -277K |
| Change in Payables | -134K | 393K | -103K | 1.72M | 469K | -153K | -1.32M |
| Cash from Investing | -73K | -125K | -13.94M | -116.32M | 14.61M | 35.43M | -20.05M |
| Capital Expenditures | -73K | -125K | -13.94M | -23.16M | -7.17M | -3.3M | -2.77M |
| CapEx % of Revenue | - | - | - | 17.76% | 0.84% | 0.33% | 0.25% |
| Acquisitions | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -90.3M | -1.01M | -373K | 46K |
| Cash from Financing | 3.68M | 13.86M | 240.99M | 7.38M | 804K | 27.25M | 39.5M |
| Debt Issued (Net) | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - |
| Other Financing | 0 | -177K | 630K | 3.58M | 804K | 113K | 1.67M |
| Net Change in Cash | - | - | - | - | - | - | - |
| Free Cash Flow | -3.74M | -5.65M | -35.42M | -61.23M | -50.56M | -48.08M | -39.37M |
| FCF Margin % | - | - | - | -46.95% | -5.89% | -4.85% | -3.49% |
| FCF Growth % | - | -0.51% | -5.27% | -0.73% | 0.17% | 0.05% | 0.18% |
| FCF per Share | -0.11 | -0.12 | -0.99 | -1.27 | -0.97 | -0.85 | -0.67 |
| FCF Conversion (FCF/Net Income) | 1.92x | 0.24x | 0.49x | 0.62x | 0.41x | 0.74x | 0.68x |
| Interest Paid | 0 | 0 | 0 | 13K | 90K | 149K | 140K |
| Taxes Paid | 0 | 0 | 8K | 7K | 147K | 3K | 53K |
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -39.19% | -23.64% | -40.73% | -28.93% | -27.83% |
| Return on Invested Capital (ROIC) | - | - | -2749.77% | -36.94% | -38.99% | -27.75% | -27.93% |
| Gross Margin | - | - | - | -115.95% | -80.21% | -66.55% | -94.03% |
| Net Margin | - | - | - | -4739.11% | -1226.89% | -613.59% | -474.31% |
| Debt / Equity | - | - | 0.01x | 0.02x | 0.02x | 0.04x | 0.04x |
| Interest Coverage | -380.80x | - | - | -213.74x | - | - | - |
| FCF Conversion | 1.92x | 0.24x | 0.49x | 0.62x | 0.41x | 0.74x | 0.68x |
| Revenue Growth | - | - | - | - | 557.82% | 15.47% | 13.91% |
Nano-X Imaging Ltd. (NNOX) reported $12.3M in revenue for fiscal year 2024.
Nano-X Imaging Ltd. (NNOX) grew revenue by 13.9% over the past year. This is steady growth.
Nano-X Imaging Ltd. (NNOX) reported a net loss of $55.7M for fiscal year 2024.
Nano-X Imaging Ltd. (NNOX) has a return on equity (ROE) of -27.8%. Negative ROE indicates the company is unprofitable.
Nano-X Imaging Ltd. (NNOX) had negative free cash flow of $46.7M in fiscal year 2024, likely due to heavy capital investments.